What is the solubility of pomalidomide? Will it affect absorption?

Pomalidomide (Pomalidomide) is an immunomodulator that is widely used to treat multiple myeloma (MM). Its pharmacological mechanism mainly enhances the immune system's recognition and clearance of cancer cells and inhibits the proliferation of cancer cells. The importance of the solubility of pomalidomide in clinical treatment cannot be ignored because it directly affects the absorption and efficacy of the drug.

First, pomalidomide is relatively poorly soluble. Its water solubility is not high, so its absorption efficiency in the body is limited. The oral absorption of drugs usually depends on their solubility in the gastrointestinal tract, and the low solubility of pomalidomide may lead to slow or incomplete absorption, thereby affecting the therapeutic effect. In order to improve its bioavailability, clinical practice usually recommends that patients take it on an empty stomach to reduce the impact of food on drug dissolution and absorption.

The solubility of pomalidomide is greatly affected bypH value, especially in the acidic environment of the stomach, its solubility is relatively limited. This means that if a patient has problems with their gastrointestinal function or has too much or too little stomach acid, the absorption of the drug may be further affected. In addition, the solubility of pomalidomide in the intestine is not completely constant and may be affected by other drugs, diet, or gastrointestinal diseases, which is also a matter of concern in clinical treatment.

However, despite pomalidomide's poor solubility, the biological properties of its design allow it to exert good efficacy in the body. Studies have shown that despite solubility issues, the drug can still reach effective concentrations in the body and exert an immunomodulatory effect after being absorbed through the gastrointestinal tract. Therefore, although solubility is an issue, the balance between pomalidomide's bioavailability and its solubility still makes it an important drug for the treatment of multiple myeloma.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide